These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7033400)

  • 21. Enhanced activity of cefepime-tazobactam (WCK 4282) against KPC-producing Enterobacteriaceae when tested in media supplemented with human serum or sodium chloride.
    Castanheira M; Duncan LR; Rhomberg PR; Sader HS
    Diagn Microbiol Infect Dis; 2017 Dec; 89(4):305-309. PubMed ID: 28969934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of minimum inhibitory and minimum bactericidal concentrations of tiamulin against field isolates of Actinobacillus pleuropneumoniae.
    Pridmore A; Burch D; Lees P
    Vet Microbiol; 2011 Aug; 151(3-4):409-12. PubMed ID: 21497460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining diagnostic methods for antimicrobial susceptibility testing - A comparative approach.
    Kłodzińska SN; Priemel PA; Rades T; Nielsen HM
    J Microbiol Methods; 2018 Jan; 144():177-185. PubMed ID: 29154899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enterococcus faecium: in vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against multiple-antibiotic-resistant strains.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1993; 39(4):254-64. PubMed ID: 8325127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method.
    Bradford PA; Petersen PJ; Young M; Jones CH; Tischler M; O'Connell J
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3903-9. PubMed ID: 16127069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Conditions influencing the activity of fosfomycin in vitro (author's transl)].
    Haag R; Vömel W
    Immun Infekt; 1979 Dec; 7(6):202-9. PubMed ID: 396228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of thienamycin.
    Shah PM
    Methods Find Exp Clin Pharmacol; 1981; 3(6):387-90. PubMed ID: 7329164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of glucose added urine on the in vitro antimicrobial activity of various antibiotics.
    Gönüllü N; Küçükbasmaci O; Büyükbaba-Boral O; Anğ-Küçüker M
    Indian J Med Res; 2008 Nov; 128(5):663-5. PubMed ID: 19179689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential application of extracts from Indian almond (Terminalia catappa Linn.) leaves in Siamese fighting fish (Betta splendens Regan) culture.
    Purivirojkul W
    Commun Agric Appl Biol Sci; 2012; 77(4):439-48. PubMed ID: 23885412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactobacillemia--report of nine cases. Important clinical and therapeutic considerations.
    Bayer AS; Chow AW; Betts D; Guze LB
    Am J Med; 1978 May; 64(5):808-13. PubMed ID: 645745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gepotidacin (GSK2140944)
    Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of minimum inhibitory concentrations.
    Andrews JM
    J Antimicrob Chemother; 2001 Jul; 48 Suppl 1():5-16. PubMed ID: 11420333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards a Standardized Method for Broth Microdilution Susceptibility Testing of Haemophilus parasuis.
    Prüller S; Turni C; Blackall PJ; Beyerbach M; Klein G; Kreienbrock L; Strutzberg-Minder K; Kaspar H; Meemken D; Kehrenberg C
    J Clin Microbiol; 2017 Jan; 55(1):264-273. PubMed ID: 27847372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus.
    Moretti MV; Fiorio M; Pasticci MB; Moretti A; Baldelli F; Pauluzzi S
    Microbiologica; 1989 Oct; 12(4):297-306. PubMed ID: 2586332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential susceptibility to tetracycline, oxytetracycline and doxycycline of the calf pathogens Mannheimia haemolytica and Pasteurella multocida in three growth media.
    Mead A; Lees P; Mitchell J; Rycroft A; Standing JF; Toutain PL; Pelligand L
    J Vet Pharmacol Ther; 2019 Jan; 42(1):52-59. PubMed ID: 30267412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro studies of tigemonam: a comparison of the minimum inhibitory and minimum bactericidal concentrations (MIC vs MBC).
    Gobernado M; Cantón E
    J Chemother; 1989 May; 1 Suppl 2():36-40. PubMed ID: 2809701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory evaluation of the serum dilution test in serious staphylococcal infection.
    Marcon MJ; Bartlett RC
    Am J Clin Pathol; 1983 Aug; 80(2):176-81. PubMed ID: 6554031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin tolerance in enterococci.
    Saribas S; Bagdatli Y
    Chemotherapy; 2004 Nov; 50(5):250-4. PubMed ID: 15528891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
    Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
    Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro Studies of Tigemonam: a Comparison of the Minimum Inhibitory and Minimum Bactericidal Concentrations (MIC vs MBC).
    Gobernado M; Cantón E
    J Chemother; 1989 May; 1(sup2):36-40. PubMed ID: 27416148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.